SynthesisFrontiers in oncology2026
Efficacy of PD-1/PD-L1 inhibitors combined with multi-targeted anti-angiogenic TKIs in advanced or metastatic NSCLC: A meta-analysis based on RCTs.
Zeqi Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.